Blog Archives

PRESS RELEASE: GLNT Secures Over $4.5 Million in Funding to Fuel New Product Development for Parkinson’s Disease and Neuroscience Education

VIEW PRESS RELEASE [PDF] April 24, 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today they have secured over $4.5 million is funding for new product development. The funding includes three new projects sponsored by the National Institutes of

Tagged with: , , , , , , , , , , , , , , , , , , , , , , , , , ,

PRESS RELEASE: GLNT Tackles Continuous Monitoring of Essential Tremor with Launch of Multi-Site Clinical Study

VIEW PRESS RELEASE [PDF] April 5, 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today they have launched a multi-site clinical study to assess continuous monitoring of essential tremor (ET) using their Kinesia technology platform. A preliminary study published

Tagged with: , , , , , , , , , , , ,

PRESS RELEASE: GLNT Begins Clinical Study to Demonstrate High Sensitivity Motor Symptom Detection in Parkinson’s Disease

VIEW PRESS RELEASE [PDF] March 23, 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they have begun a clinical study to assess the sensitivity of their Kinesia system to detect subtle motor function changes in patients with

Tagged with: , , , , , , , , , , , , , , , , , ,

PRESS RELEASE: GLNT Awarded Patent for Technology to Assess Parkinson’s Disease

VIEW PRESS RELEASE [PDF] 8MAR2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they have received allowance of claims from the U.S. Patent Office for an application covering their Movement Disorder Monitoring System and Method for quantitative assessment

Tagged with: , , , , , , , , , , , , , , , , , , , ,

Objective Measure of Upper Extremity Motor Impairment in Parkinsons Disease with Inertial Sensors

J. Hoffman, J. McNames Conf Proc IEEE Eng Med Biol Soc. 2011;2011:4378-81

Tagged with: , , , , ,

Feasibility of Home-Based Automated Parkinson’s Disease Motor Assessment

T. Mera, D. Heldman, A. Espay, M. Payne, J. Giuffrida J Neurosci Methods. 2012 Jan 15;203(1):152-6

Tagged with: , , ,

Differential Response of Speed, Amplitude, and Rhythm to Dopaminergic Medications in Parkinson’s Disease

A. Espay, J. Giuffrida, R. Chen, M. Payne, F. Mazzella, E. Dunn, J. Vaughan, A. Duker, A. Sahay, S. Kim, F. Revilla, D. Heldman Mov Disord. 2011 Dec;26(14):2504-8

Tagged with: , , , , ,

Healthcare Sensor Networks: Challenges Toward Practical Implementation

Chapter 10: Ambulatory and Remote Monitoring Of Parkinson’s Disease Motor Symptoms J. Giuffrida, E. Rapp

Tagged with: , , , , ,

Acute effects of passive leg cycling on upper extremity tremor and bradykinesia in Parkinson’s disease

A. Ridgel, M. Muller, C. Kim, E. Fickes, T. Mera Phys Sportsmed. 2011 Sep;39(3):83-93

Tagged with: , , , , , ,

PRESS RELEASE: Great Lakes NeuroTechnologies Receives Nearly $2 Million In New Funding To Expand Home-Based Technologies For Monitoring Movement Disorders

VIEW PRESS RELEASE [PDF] 01 SEPT 2011: Cleveland OH – Great Lakes NeuroTechnologies was recently awarded two NIH SBIR grants: $1.7 million in Phase II funding from the National Institute on Aging to develop ETSense ™, an adaptive, portable essential

Tagged with: , , , , , , , , ,